Pandemic preparedness: A new report has sounded the alarm on the urgent need to address global disparities and foster interdisciplinary cooperation to effectively prepare for and respond to future pandemics.
While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.
Two divisions of Active Care Group – Christchurch Group and Remeo – discuss the importance of infection prevention and control in the healthcare sector in light of COVID-19.
As of midnight tonight (20 December), London and the South East will enter strict Tier 4 restrictions - which includes no household mixing over Christmas, and no commuting to work.
SureWash, a CPD certified hand hygiene training company has been helping healthcare facilities globally with the fight against COVID-19. Founder and CTO, Dr Gerard Lacey tells us about their technology and what comes next for the company.
Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.